Maxime Bélondrade

500 total citations
14 papers, 315 citations indexed

About

Maxime Bélondrade is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Maxime Bélondrade has authored 14 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Neurology and 2 papers in Physiology. Recurrent topics in Maxime Bélondrade's work include Prion Diseases and Protein Misfolding (12 papers), Neurological diseases and metabolism (4 papers) and Alzheimer's disease research and treatments (2 papers). Maxime Bélondrade is often cited by papers focused on Prion Diseases and Protein Misfolding (12 papers), Neurological diseases and metabolism (4 papers) and Alzheimer's disease research and treatments (2 papers). Maxime Bélondrade collaborates with scholars based in France, United Kingdom and Germany. Maxime Bélondrade's co-authors include Sylvain Lehmann, Daisy Bougard, Simon Nicot, Vincent Béringue, Chantal Fournier‐Wirth, Joliette Coste, Robert Will, Richard Knight, Danielle Casanova and Stéphane Haı̈k and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Maxime Bélondrade

14 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxime Bélondrade France	12	262	94	48	44	34	14	315
Ειrini Kanata Greece	12	193 0.7×	82 0.9×	34 0.7×	45 1.0×	33 1.0×	25	302
J.P. Deslys France	12	485 1.9×	260 2.8×	48 1.0×	105 2.4×	78 2.3×	17	548
Emilie Jaumain France	13	639 2.4×	266 2.8×	54 1.1×	183 4.2×	22 0.6×	16	704
Katie Williams United States	10	299 1.1×	191 2.0×	75 1.6×	35 0.8×	21 0.6×	26	355
Max Nunziante Germany	8	313 1.2×	139 1.5×	61 1.3×	120 2.7×	12 0.4×	10	344
Hikari Tanaka Japan	9	163 0.6×	75 0.8×	73 1.5×	6 0.1×	27 0.8×	18	326
Grace I. Hallinan United States	8	144 0.5×	53 0.6×	113 2.4×	20 0.5×	24 0.7×	13	230
Julie Ann Edgeworth United Kingdom	7	300 1.1×	106 1.1×	25 0.5×	67 1.5×	22 0.6×	7	317
Mathias Heikenwaelder Germany	3	254 1.0×	125 1.3×	74 1.5×	85 1.9×	28 0.8×	5	330
Tiziana Sonati Switzerland	5	365 1.4×	218 2.3×	110 2.3×	128 2.9×	22 0.6×	5	392

Countries citing papers authored by Maxime Bélondrade

Since Specialization

Citations

This map shows the geographic impact of Maxime Bélondrade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Bélondrade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Bélondrade more than expected).

Fields of papers citing papers by Maxime Bélondrade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Bélondrade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Bélondrade. The network helps show where Maxime Bélondrade may publish in the future.

Co-authorship network of co-authors of Maxime Bélondrade

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Bélondrade. A scholar is included among the top collaborators of Maxime Bélondrade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Bélondrade. Maxime Bélondrade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Janot, Jean‐Marc, Mathilde Lepoitevin, Véronique Perrier, et al.. (2021). Detection of Amyloid-β Fibrils Using Track-Etched Nanopores: Effect of Geometry and Crowding. ACS Sensors. 6(10). 3733–3743. 24 indexed citations

Bélondrade, Maxime, Simon Nicot, Michele Angelo Di Bari, et al.. (2021). Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt–Jakob disease prions is strongly seed and substrate dependent. Scientific Reports. 11(1). 4058–4058. 8 indexed citations

Bélondrade, Maxime, Simon Nicot, Laëtitia Herzog, et al.. (2020). Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies. mSphere. 5(1). 19 indexed citations

Nicot, Simon, Jérémy Verchère, Maxime Bélondrade, et al.. (2019). Seeded propagation of α‐synuclein aggregation in mouse brain using protein misfolding cyclic amplification. The FASEB Journal. 33(11). 12073–12086. 13 indexed citations

Relaño-Ginés, Aroa, Sylvain Lehmann, Maxime Bélondrade, et al.. (2018). Lithium as a disease-modifying agent for prion diseases. Translational Psychiatry. 8(1). 163–163. 11 indexed citations

Bougard, Daisy, Maxime Bélondrade, Sylvain Lehmann, et al.. (2018). Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification. Emerging infectious diseases. 24(7). 1364–1366. 22 indexed citations

Bélondrade, Maxime, Simon Nicot, Vincent Béringue, et al.. (2016). Rapid and Highly Sensitive Detection of Variant Creutzfeldt - Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies. PLoS ONE. 11(1). e0146833–e0146833. 22 indexed citations

Bougard, Daisy, Jean‐Philippe Brandel, Maxime Bélondrade, et al.. (2016). Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Science Translational Medicine. 8(370). 370ra182–370ra182. 96 indexed citations

Lehmann, Sylvain, Aroa Relaño-Ginés, Danielle Casanova, et al.. (2014). Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder. PLoS ONE. 9(2). e88797–e88797. 16 indexed citations

10.

Relaño-Ginés, Aroa, Audrey Gabelle, Claire Hamela, et al.. (2013). Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases. PLoS Pathogens. 9(8). e1003485–e1003485. 25 indexed citations

11.

Bélondrade, Maxime, et al.. (2011). HEPES inhibits the conversion of prion protein in cell culture. Journal of General Virology. 92(5). 1244–1250. 5 indexed citations

12.

Roche, Stéphane, Manuela Pastore, Danielle Casanova, et al.. (2010). Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells. Prion. 4(4). 292–301. 13 indexed citations

13.

Lehmann, Sylvain, Manuela Pastore, Christine Rogez‐Kreuz, et al.. (2009). New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. Journal of Hospital Infection. 72(4). 342–350. 30 indexed citations

14.

Chasseigneaux, Stéphanie, Manuela Pastore, Janice Britton‐Davidian, et al.. (2008). Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines. Archives of Virology. 153(9). 1693–1702. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact